Short-term, intermediate-term and long-term risks of acute coronary syndrome in cohorts of patients with RA starting biologic DMARDs: results from four Nordic countries

Benedicte Delcoigne, Lotta Ljung, Sella A. Provan, Bente Glintborg, Merete Lund Hetland, Kathrine Lederballe Gron, Ritva Peltomaa, Heikki Relas, Carl Turesson, Bjorn Gudbjornsson, Brigitte Michelsen, Johan Askling

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalAnnals of the Rheumatic Diseases
Volume81
Issue number6
Pages (from-to)789-797
Number of pages9
ISSN0003-4967
DOIs
Publication statusPublished - Jun 2022
MoE publication typeA1 Journal article-refereed

Fields of Science

  • rheumatoid arthritis
  • tumor necrosis factor inhibitors
  • cardiovascular diseases
  • biological therapy
  • NECROSIS-FACTOR INHIBITORS
  • RHEUMATOID-ARTHRITIS
  • CARDIOVASCULAR EVENTS
  • REGISTER
  • MORTALITY
  • DISEASE
  • AGENTS
  • 3121 General medicine, internal medicine and other clinical medicine

Cite this